Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
UBS
Merck
Argus Health
Queensland Health
Express Scripts
McKinsey
Fuji
Farmers Insurance
Johnson and Johnson

Generated: October 23, 2017

DrugPatentWatch Database Preview

Drug Master Files for: MONTELUKAST SODIUM

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
16243AII11/15/2002DELMAR CHEMICALS INCMONTELUKAST SODIUM THIOL ACID
19829AII10/4/2006TEVA PHARMACEUTICAL INDUSTRIES LTDMONTELUKAST SODIUM
20035AII12/14/2006DR REDDYS LABORATORIES LTDMONTELUKAST SODIUM
20425AII3/26/2007MYLAN LABORATORIES LTDMONTELUKAST SODIUM USP
20564III5/31/2007UNIMARK REMEDIES LTDMONTELUKAST SODIUM
20580AII6/7/2007MSN PHARMACHEM PRIVATE LTDMONTELUKAST SODIUM USP [ROUTE CODE - MT]
21702AII6/16/2008FORMOSA LABORATORIES INCMONTELUKAST SODIUM
21893III8/14/2008UNIMARK REMEDIES LTDMONTELUKAST SODIUM (NI)
22484AII2/5/2009MSN PHARMACHEM PRIVATE LTDMONTELUKAST SODIUM USP [ROUTE CODE - MB]
23495AII1/29/2010APOTEX PHARMACHEM INCMONTELUKAST SODIUM USP
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Argus Health
UBS
Cipla
Fish and Richardson
Queensland Health
Dow
Federal Trade Commission
McKesson
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot